ClinConnect ClinConnect Logo
Search / Trial NCT06311591

Efficacy, Effectiveness, and Implementation of Jaspr Health in Emergency Department- Part B

Launched by UNIVERSITY OF MASSACHUSETTS, WORCESTER · Mar 7, 2024

Trial Information

Current as of November 14, 2025

Enrolling by invitation

Keywords

Suicide Self Harm Attempt Ideation Suicidal Thought Suicidal Plan Crisis Intervention Suicide Prevention Emotional Support Mental Health Behavioral Health Psychiatry Emergency Department Technology Mobile Application Implementation Safety Plan Lethal Means

ClinConnect Summary

This study is looking at Jaspr Health, a tablet-based program used in emergency departments to help prevent suicide. It combines an evidence-based suicide risk interview, safety planning, and guidance to reduce dangerous means, plus coping skills videos and other resources. The goal is to see if using Jaspr in the ED helps clinicians deliver proven suicide-prevention care more consistently and supports patients after they leave the ED. It’s a large, real-world evaluation across several hospitals in Colorado and Ohio, with results expected through 2027.

Who can participate and what to expect: Adults 18 years and older who are identified as at risk for suicide on a screening test can be eligible if they can read English (or have someone to read and enter questions for them) and are able to engage with the Jaspr app. People who participate may receive the Jaspr intervention during their ED visit, or may receive usual care without Jaspr, depending on the site. If enrolled, you would use the Jaspr app to complete the risk interview, create a safety plan, and receive counseling about reducing risk and managing distress, with access to coping skills and a library of videos after the visit. Your health information will be used to follow outcomes for up to 12 months. This is currently enrolling by invitation at selected EDs, and the study plans to include up to about 28,000 participants.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • \>= 18 years old
  • Positive for suicide risk on screener
  • Reads English, or has proxy available to read and enter questions
  • Exclusion Criteria:
  • Cognitively or emotionally incapable of engaging with Jaspr

About University Of Massachusetts, Worcester

The University of Massachusetts Worcester is a leading academic institution dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the university integrates cutting-edge scientific inquiry with a commitment to improving patient outcomes. Its collaborative approach engages a diverse range of experts, fostering interdisciplinary research that addresses pressing health challenges. With a focus on ethical standards and regulatory compliance, the University of Massachusetts Worcester plays a pivotal role in translating scientific discoveries into practical applications that enhance medical practice and patient care.

Locations

Colorado Springs, Colorado, United States

Columbus, Ohio, United States

Aurora, Colorado, United States

Columbus, Ohio, United States

Patients applied

0 patients applied

Trial Officials

Edwin D Boudreaux, PhD

Principal Investigator

UMass Chan Medical School

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported